Tag: BetterLife Pharma - Psychedelic Alpha

Psilocybin Alpha is becoming Psychedelic Alpha - Please bear with us.

Read more about the article BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model

BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model

Post published:February 15, 2022
Post category:Press Release

Read more about the article BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001

BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001

Post published:January 20, 2022
Post category:Press Release

Read more about the article BetterLife Obtains Positive In Vivo Oral Bioavailability, Food Effect and Pharmacokinetics Data for BETR-001

BetterLife Obtains Positive In Vivo Oral Bioavailability, Food Effect and Pharmacokinetics Data for BETR-001

Post published:January 18, 2022
Post category:Press Release

Read more about the article BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders

BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders

Post published:September 27, 2021
Post category:Press Release

Read more about the article BetterLife Announces Closing of a Non-Brokered Private Placement

BetterLife Announces Closing of a Non-Brokered Private Placement

Post published:May 14, 2021
Post category:Press Release

Read more about the article BetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs

BetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs

Post published:April 29, 2021
Post category:Press Release

Read more about the article Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory Advisor

Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory Advisor

Post published:April 8, 2021
Post category:Press Release

Read more about the article BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003

BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003

Post published:March 11, 2021
Post category:Press Release

Read more about the article BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies

BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies

Post published:March 8, 2021
Post category:Press Release

Read more about the article BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing

BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing

Post published:March 3, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.